Deprenyl: from chemical synthesis to neuroprotection.

K. Magyar, M. Palfi, Veronica Jenei, E. Szoko

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review


During the last decades (-)-deprenyl has become the golden standard of MAO-B inhibitors. It possesses dopamine potentiating and antioxidant properties; however, its effects cannot be explained solely by the enzyme inhibitory action. (-)-Deprenyl prevents the toxicity of certain selective neurotoxins and recently it was demonstrated to increase cell-cell adhesion as well. The complexity of its pharmacological effects reflects the action of both the parent compound and the active metabolites. (-)-Deprenyl and related propargylamines (DRPs) show neuroprotective features in a variety of in vitro and in vivo models that is dependent on the propargyl moiety. The main presumptive targets to date include glyceraldehyde-3-phosphate dehydrogenase, poly(ADP-ribose) polymerase, some kinase cascades, as well as pro- and antiapoptotic proteins, beside the inhibition of MAO-B. The antiapoptotic activity of DRPs converges upon the maintenance of mitochondrial integrity, due to the initiation of a comp
Sidor (från-till)143-156
TidskriftJournal of neural transmission. Supplementum
StatusPublished - 2006

Ämnesklassifikation (UKÄ)

  • Cancer och onkologi


Utforska forskningsämnen för ”Deprenyl: from chemical synthesis to neuroprotection.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här